Pulmonary Fibrosis Under Chemotherapy with Oxaliplatin, 5-fluorouracil, and Leucovorin | Zendy

Jin Yong Jung | Zendy; Gyu Young Hur | Zendy; Ki Hwan Jung | Zendy; Hae Chul Jung | Zendy; Sung Yong Lee | Zendy; In Keun Choi | Zendy; Sang Yeub Lee | Zendy; Je Hyeong Kim | Zendy; Jae Hong Seo | Zendy; Chol Shin | Zendy; Jae Jeong Shim | Zendy; Kwang Ho In | Zendy; Kyung Ho Kang | Zendy; Se Hwa Yoo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pulmonary Fibrosis Under Chemotherapy with Oxaliplatin, 5-fluorouracil, and Leucovorin

Author(s) -

Jin Yong Jung,

Gyu Young Hur,

Ki Hwan Jung,

Hae Chul Jung,

Sung Yong Lee,

In Keun Choi,

Sang Yeub Lee,

Je Hyeong Kim,

Jae Hong Seo,

Chol Shin,

Jae Jeong Shim,

Kwang Ho In,

Kyung Ho Kang,

Se Hwa Yoo

Publication year - 2005

Publication title -

tuberculosis and respiratory diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.837

H-Index - 24

eISSN - 2005-6184

pISSN - 1738-3536

DOI - 10.4046/trd.2005.59.5.536

Subject(s) - oxaliplatin , medicine , folfox , fluorouracil , regimen , chemotherapy , neutropenia , combination chemotherapy , oncology , gastroenterology , pulmonary toxicity , colorectal cancer , toxicity , cancer

The combination of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) has recently been shown to be beneficial in advanced colorectal and gastric cancers. The side effects of this regimen include neutropenia, diarrhea and neurosensory toxicity. However, case reports on the pulmonary toxicities of this regimen are very limited. Especially, the development of pulmonary fibrosis has never been cited in the literature. Herein is reported the case of a patient treated with oxaliplatin, 5-fluorouracil and leucovorin combination chemotherapy in whom pulmonary fibrosis developed, but which improved after steroid pulse therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research